通过有针对性的CRISPR/dCas9介导的表观遗传编辑来使人类HTT沉默
Yi Lin Tay1, Sarah B Thomson2, Silvia Hnatova1
1Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Immunos, Singapore, Singapore.
Journal of Huntington's disease
|January 22, 2026
概括
使用CRISPR/dCas9-DNMT3A的向DNA甲基化有效地使HTT基因沉默,为亨廷顿病提供了潜在的新疗法.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因法规 基因法规
- 神经退行性疾病 神经退行性疾病
背景情况:
- 基因沉默是主导单基因疾病的关键治疗策略.
- 目前的方法,如RNA干扰,往往是短暂的.
- 表观遗传编辑为基因沉默提供了一种替代方法.
研究的目的:
- 为了研究dCas9-DNMT3A介导的DNA甲基化对沉默HTT基因的有效性.
- 评估这种表观遗传编辑策略在治疗亨廷顿病方面的潜力.
主要方法:
- 使用了CRISPR/dCas9与DNA甲基转移酶3A (dCas9-DNMT3A) 融合.
- 针对性DNA甲基化对HTT基因的特定区域.
- 分析了不同HTT表达水平的组织中的DNA甲基化概况.
主要成果:
- 定向DNA甲基化导致HTT表达的强大而急性沉默.
- 通过针对5'UTR和促进区域,实现了长期沉默 (长达30天).
- 在HTTT的低甲基调控区域观察到成功的基因沉默.
结论:
- 有针对性的DNA甲基化编辑可以有效地使HTT基因沉默.
- 这种表观遗传方法显示出作为亨廷顿病治疗策略的前景.
- 长期,可逆的基因沉默的潜力使其成为一个有吸引力的治疗选择.
相关概念视频
CRISPR
57.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.6K
CRISPR/Cas9 Genome Editing
1.8K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.8K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
CRISPR and crRNAs
18.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.8K
RNA Editing
9.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.8K


